Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical landscape of macrophage-reprogramming cancer immunotherapies
Jenna H. Rannikko, Maija Hollmén
British Journal of Cancer (2024) Vol. 131, Iss. 4, pp. 627-640
Open Access | Times Cited: 16

Showing 16 citing articles:

Exploring CAR-macrophages in non-tumor diseases: Therapeutic potential beyond cancer
Yizhao Chen, Qianling Xin, Mengjuan Zhu, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects
Yi‐Jing Hsiao, Min-Shu Hsieh, Gee‐Chen Chang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Targeting CXCL8 signaling sensitizes HNSCC to anlotinib by reducing tumor-associated macrophage-derived CLU
Xin Hu, Yikang Ji, Mi Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges
Jeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 470-470
Open Access
Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses
Rita Turpin, Karita Peltonen, Jenna H. Rannikko, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Bacterial-Mediated In Situ Engineering of Tumour-Associated Macrophages for Cancer Immunotherapy
Gabriela Christina Kuhl, Mark Tangney
Cancers (2025) Vol. 17, Iss. 5, pp. 723-723
Open Access
A facile automated multiple‐well platform of immunized tumor organoid cultures in ECM‐mimicked hydrogels for chem‐immunotherapy evaluation
Ruizhi Tang, Xi‐Qiu Liu
Deleted Journal (2025)
Open Access
Harnessing myeloid cells in cancer
Suyeon Park, Ekaterina Pylaeva, Vikas Bhuria, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Histone acetylation modulators in breast cancer
Xueying Yuan, Jeffrey M. Rosen
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Reprogram to heal: Macrophage phenotypes as living therapeutics
Sheyda Ghamangiz, Abbas Jafari, Hadi Maleki, et al.
Life Sciences (2025), pp. 123601-123601
Open Access
Design and Synthesis of FR-β Targeting Chimeric Molecules for Reprogramming Tumor-Associated Macrophages Using 6-Substituted Pyrrolo[2,3-d]pyrimidines as Targeting Ligands
Lixiao Guo, Binghao Guo, Yuqing Wang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Peptide‐Drug Conjugate for Therapeutic Reprogramming of Tumor‐Associated Macrophages in Breast Cancer
Anni Lepland, Elisa Peranzoni, Uku Haljasorg, et al.
Advanced Science (2025)
Open Access
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer
Maria Tredicine, Matteo Mucci, Antonio Recchiuti, et al.
FEBS Letters (2025)
Open Access
MHC class II+ macrophage differentiation is impaired in metastasized lungs via PGE2 receptor EP2
Mi Reu Jeong, Justin H. Hwang, Murim Choi, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115574-115574
Closed Access
The role of macrophage migratory behavior in development, homeostasis and tumor invasion
Michael W. Murrey, Isaac KS Ng, Fiona J. Pixley
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Therapeutic Tumor Macrophage Reprogramming in Breast Cancer Through a Peptide-Drug Conjugate
Anni Lepland, Elisa Peranzoni, Uku Haljasorg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Enhancing the anti-tumor activity and reprogramming M2 macrophages by delivering siRNAs against SIRPα and STAT6 via M1 exosomes and combining with anti-PD-L1
Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi, Nazanin Mojtabavi, et al.
Life Sciences (2024), pp. 123311-123311
Closed Access
Page 1

Scroll to top